Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
7.57
+0.10 (1.34%)
At close: Apr 23, 2024, 4:00 PM
7.67
+0.10 (1.32%)
Pre-market: Apr 24, 2024, 7:07 AM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Altimmune stock have an average target of 15, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 98.15% from the current stock price of 7.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +58.52% | Apr 1, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +164.20% | Mar 28, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +164.20% | Feb 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $13 | Hold | Initiates | $13 | +71.73% | Jan 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +98.15% | Dec 1, 2023 |
Financial Forecast
Revenue This Year
42.08M
from 426.00K
Increased by 9,778.64%
Revenue Next Year
n/a
from 42.08M
EPS This Year
-1.01
from -1.66
EPS Next Year
-1.79
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 262.5M | n/a | n/a | 135.1M | 1.7B |
| Avg | 42.1M | n/a | n/a | 69.8M | 488.3M |
| Low | n/a | n/a | n/a | 31.9M | 132.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 61,519.7% | - | - | - | 2,364.1% |
| Avg | 9,778.6% | - | - | - | 600.0% |
| Low | - | - | - | - | 89.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.04 | -1.28 | -1.37 | -0.18 | 15.34 |
| Avg | -1.01 | -1.79 | -2.31 | -0.78 | 4.51 |
| Low | -1.90 | -3.10 | -4.85 | -1.25 | -1.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.